Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Deferred Taxes: 2020-2024

Historic Deferred Taxes for Revolution Medicines (RVMD) over the last 1 years, with Dec 2024 value amounting to $762,000.

  • Revolution Medicines' Deferred Taxes rose 1672.09% to $762,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $569,000, marking a year-over-year increase of 425.14%. This contributed to the annual value of $762,000 for FY2024, which is 80.51% down from last year.
  • As of Q4 2024, Revolution Medicines' Deferred Taxes stood at $762,000, which was up 1,672.09% from $43,000 recorded in Q4 2023.
  • In the past 5 years, Revolution Medicines' Deferred Taxes registered a high of $762,000 during Q4 2024, and its lowest value of -$359,000 during Q4 2020.
  • In the last 3 years, Revolution Medicines' Deferred Taxes had a median value of $123,000 in 2022 and averaged $309,333.
  • Per our database at Business Quant, Revolution Medicines' Deferred Taxes crashed by 65.04% in 2023 and then soared by 1,672.09% in 2024.
  • Over the past 4 years, Revolution Medicines' Deferred Taxes (Quarterly) stood at -$359,000 in 2020, then reached $123,000 in 2022, then plummeted by 65.04% to $43,000 in 2023, then skyrocketed by 1,672.09% to $762,000 in 2024.
  • Its Deferred Taxes stands at $762,000 for Q4 2024, versus $43,000 for Q4 2023 and $123,000 for Q4 2022.